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This Article contains errors in [Table 1](#t1){ref-type="table"}, where the column headings 'Without SMs (n = 105)' and 'With SMs (n = 23) are inverted. The correct [Table 1](#t1){ref-type="table"} appears below.

###### Clinical characteristics of HNSCC patients in a 13 years of follow-up cohort.

  Characteristics           HNSCC male patients (n = 128)     P value    
  ------------------------ ------------------------------- ------------- ------
  Age (years, mean ± SD)             52.8 ± 12.2            51.3 ± 10.6   0.56
  Primary cancer site                                                    
   Buccal                             7 (30.4%)             48 (45.7%)    0.83
   Tongue                             9 (39.1%)             33 (31.4%)   
   Gum                                3 (12.0%)             12 (11.4%)   
   Palate                             2 (8.7%)               5 (4.8%)    
   Lip                                1 (4.3%)               2 (1.9%)    
   Oropharynx                         1 (4.3%)               2 (1.9%)    
   Hypopharynx                        0 (0.0%)               1 (1.0%)    
   Larynx                             0 (0.0%)               1 (1.0%)    
  Stage                                                                  
   I                                  4 (17.4%)             15 (14.3%)    0.79
   II                                 3 (13.0%)             24 (22.9%)   
   III                                6 (26.1%)             27 (25.7%)   
   IV                                 9 (39.1%)             38 (36.2%)   
  Radiotherapy                                                           
   Yes                               14 (60.9%)             71 (67.6%)    0.51
   No                                 8 (34.8%)             27 (25.7%)   
  Chemotherapy                                                           
   Yes                               11 (47.8%)             58 (55.2%)    0.28
   No                                12 (52.2%)             43 (41.0%)   
  Recurrence                                                             
   Yes                               12 (52.2%)             27 (25.7%)    0.02
   No                                11 (47.8%)             78 (74.3%)   
  Fatality                                                               
   Yes                                7 (30.4%)             15 (14.3%)    0.06
   No                                16 (69.6%)             90 (85.7%)   
